Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

373 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
Diabetes Control and Complications Trial Research Group; Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, Rand L, Siebert C. Diabetes Control and Complications Trial Research Group, et al. N Engl J Med. 1993 Sep 30;329(14):977-86. doi: 10.1056/NEJM199309303291401. N Engl J Med. 1993. PMID: 8366922 Free article. Clinical Trial.
Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial.
Monnier VM, Bautista O, Kenny D, Sell DR, Fogarty J, Dahms W, Cleary PA, Lachin J, Genuth S. Monnier VM, et al. Diabetes. 1999 Apr;48(4):870-80. doi: 10.2337/diabetes.48.4.870. Diabetes. 1999. PMID: 10102706 Free PMC article.
Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group; Lachin JM, Genuth S, Cleary P, Davis MD, Nathan DM. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group, et al. Among authors: lachin jm. N Engl J Med. 2000 Feb 10;342(6):381-9. doi: 10.1056/NEJM200002103420603. N Engl J Med. 2000. PMID: 10666428 Free PMC article. Clinical Trial.
A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes.
Viberti G, Kahn SE, Greene DA, Herman WH, Zinman B, Holman RR, Haffner SM, Levy D, Lachin JM, Berry RA, Heise MA, Jones NP, Freed MI. Viberti G, et al. Among authors: lachin jm. Diabetes Care. 2002 Oct;25(10):1737-43. doi: 10.2337/diacare.25.10.1737. Diabetes Care. 2002. PMID: 12351470 Clinical Trial.
Implications of the United kingdom prospective diabetes study.
Genuth S, Eastman R, Kahn R, Klein R, Lachin J, Lebovitz H, Nathan D, Vinicor F; American Diabetes Association. Genuth S, et al. Diabetes Care. 2003 Jan;26 Suppl 1:S28-32. doi: 10.2337/diacare.26.2007.s28. Diabetes Care. 2003. PMID: 12502617 No abstract available.
Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus.
Nathan DM, Lachin J, Cleary P, Orchard T, Brillon DJ, Backlund JY, O'Leary DH, Genuth S; Diabetes Control and Complications Trial; Epidemiology of Diabetes Interventions and Complications Research Group. Nathan DM, et al. N Engl J Med. 2003 Jun 5;348(23):2294-303. doi: 10.1056/NEJMoa022314. N Engl J Med. 2003. PMID: 12788993 Free PMC article. Clinical Trial.
373 results